Skip to content

Study · Measured the body's own peptide · 2008

1 result

Proteomic analysis permits the identification of new biomarkers of arterial wall remodeling in hypertension.

Delbosc S, Haloui M, Louedec L, Dupuis M, Cubizolles M, Podust VN, Fung ET, Michel JB, Meilhac O

Molecular medicine (Cambridge, Mass.)1 Jul 2008Cited by 25 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Mechanism

    In Fischer rats given L-NAME, aortic secretion of thymosin beta4 was differentially increased, among four biomarkers linked to aortic wall hypertrophic remodeling.

    In plain wordsIn rats, more of the body's own thymosin beta4 was released by the aorta in the strain with greater blood vessel remodeling.

    Outcome
    IncreaseAortic secretion of thymosin beta4 in L-NAME hypertension
    Study

    ratn: not reported in source

    Fischer rats with L-NAME induced hypertension
    Comparator
    Brown Norway rats and controls
    Outcome group
    Vascular function · Cardiovascular

    Source sentences

    Summary
    Proteomic analysis of secreted aortic proteins by SELDI-TOF MS allowed detection of four mass-to-charge ratio (m/z) peaks whose corresponding proteins were identified as ubiquitin, smooth muscle (SM) 22alpha, thymosin beta4, and C-terminal fragment of filamin A, differentially secreted in Fischer ra…
    2 context sentences
    Summary · context
    The greater susceptibility of Fischer rats is associated with aortic wall hypertrophic remodeling, reflected by increased aortic secretion of four identified biomarkers.
    Summary · context
    Fischer and Brown Norway (BN) rats were divided into a control group and a group receiving low-dose N(Omega)-nitro-L-arginine methyl ester (L-NAME), a hypertensive drug, interfering with endothelial function.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.